Brief: Jaguar Health Napo And Alivus Enter New Manufacturing And Supply Agreement For Crofelemer - SEC Filing
14/07/2026 21:29
BRIEF-Jaguar Health Napo And Alivus Enter New Manufacturing And Supply Agreement For Crofelemer - SEC Filing July 14 (Reuters) - SEC Filing:
JAGUAR HEALTH - NAPO AND ALIVUS ENTER NEW MANUFACTURING AND SUPPLY AGREEMENT FOR CROFELEMER ON JULY 9, 2026 - SEC FILING
JAGUAR HEALTH - 2026 AGREEMENT INCLUDES MINIMUM PURCHASE COMMITMENT FOR CROFELEMER BY NAPO - SEC FILING
JAGUAR HEALTH - 2026 AGREEMENT SET TO EXPIRE ON MARCH 31, 2029 - SEC FILING
Source text: [ID:n0001193125-26-303190]
Further company coverage: JAGX.O